Enable Injections

Enable Injections, Inc. is a healthcare innovation company based in Cincinnati, Ohio, founded in 2010. The company specializes in wearable drug delivery systems, focusing on enhancing patient treatment experiences. Its flagship product, the enFuse® On-Body Platform, is a mechanical, hands-free device designed for the subcutaneous delivery of high-volume and high-viscosity biologic therapeutics. The enFuse® Technology allows for self-administration of therapies that typically require intravenous infusions in a clinical setting. This disposable, body-worn injector is compatible with standard container closure systems and is aimed at treating chronic diseases such as cancer and autoimmune disorders. Enable Injections collaborates with pharmaceutical and biotechnology companies to integrate its delivery systems into drug development, supporting the transition of IV therapies to subcutaneous delivery. The company is recognized for addressing the demand for patient-centric drug delivery solutions, aiming to reduce healthcare costs and improve patient comfort and mobility during treatment.

Medical Devices Cincinnati, United States ~177 employees Private · Series C

Work at Enable Injections in HR or recruiting? Claim this page

Employees
177
+4.7% in the 3 months to Jun 2025
Revenue / employee
$140K
Revenue ~$24.8M
Total funding
$345M
Last round Series C, Jan 2022
12-month attrition
11.1%
Tech: 13.8%
H1B sponsor
NA

Headcount trend

Enable Injections went from 159 employees in Jul 2023 to 177 in Jun 2025. Jan to Jun 2025: 12 people joined, 5 left.

Headcount data through Jun 2025

Funding rounds

Total funding$345M
Funding rounds5
Investors10

Org structure

Headcount by department

Other70
Engineering61
Operations16
Finance11
HR8
Design5
Sales4
Marketing2

Hiring now

Enable Injections FAQ

How many employees does Enable Injections have?

Enable Injections has about 177 employees, up 4.7% over the 3 months to Jun 2025.

What is Enable Injections's revenue per employee?

Enable Injections makes about $140K in revenue per employee, based on $24.8M annual revenue and 177 employees.

How much funding has Enable Injections raised?

Enable Injections has raised $345M in total funding; its latest round was Series C in Jan 2022.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.